The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 14, 2023

Filed:

Jun. 01, 2017
Applicant:

Twincore Zentrum Für Experimentelle Und Klinische Infektionsforschung Gmbh, Hannover, DE;

Inventors:

Thomas Pietschmann, Hannover, DE;

Richard Brown, Hannover, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/18 (2006.01); C12N 15/10 (2006.01); C12N 15/11 (2006.01); G01N 33/00 (2006.01); A01K 67/027 (2006.01); A61P 31/14 (2006.01); A61K 48/00 (2006.01); C07K 14/705 (2006.01); C12N 15/113 (2010.01); G01N 33/50 (2006.01); C07K 14/00 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A01K 67/0278 (2013.01); A01K 67/0276 (2013.01); A61K 48/0066 (2013.01); A61P 31/14 (2018.01); C07K 14/00 (2013.01); C07K 14/705 (2013.01); C07K 14/7056 (2013.01); C12N 15/113 (2013.01); G01N 33/5091 (2013.01); A01K 2217/052 (2013.01); A01K 2217/054 (2013.01); A01K 2217/058 (2013.01); A01K 2217/072 (2013.01); A01K 2217/075 (2013.01); A01K 2267/0337 (2013.01); A61K 38/00 (2013.01); C12N 2310/14 (2013.01); C12N 2770/24211 (2013.01);
Abstract

The present invention pertains to a non-human genetically modified animal with increased susceptibility to infection with a human virus. The invention suggests to genetically impair the expression of newly identified viral infection repression factors CD302, Cr11, Ndufc2, AW112010, Scarb2 and Zc3hav1, which markedly improves infection with human viruses in none-human hosts. Furthermore provided are methods for the generation of the animal of the invention, methods for increasing or reducing the susceptibility of a cell to viral infection, methods for screening novel modulators of viral infection as well as new therapy options for the treatment of viral diseases, in particular hepatitis C.


Find Patent Forward Citations

Loading…